title: Alzheimer's disease risk assessment using large-scale machine learning methods.
abstract: The goal of this work is to introduce new metrics to assess risk of Alzheimer's disease (AD) which we call AD Pattern Similarity (AD-PS) scores. These metrics are the conditional probabilities modeled by large-scale regularized logistic regression. The AD-PS scores derived from structural MRI and cognitive test data were tested across different situations using data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study. The scores were computed across groups of participants stratified by cognitive status, age and functional status. Cox proportional hazards regression was used to evaluate associations with the distribution of conversion times from mild cognitive impairment to AD. The performances of classifiers developed using data from different types of brain tissue were systematically characterized across cognitive status groups. We also explored the performance of anatomical and cognitive-anatomical composite scores generated by combining the outputs of classifiers developed using different types of data. In addition, we provide the AD-PS scores performance relative to other metrics used in the field including the Spatial Pattern of Abnormalities for Recognition of Early AD (SPARE-AD) index and total hippocampal volume for the variables examined.
authors.affiliation: Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.
authors.forename: Ramon
authors.initials: R
authors.lastname: Casanova
authors.forename: Fang-Chi
authors.initials: FC
authors.lastname: Hsu
authors.forename: Kaycee M
authors.initials: KM
authors.lastname: Sink
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Rapp
authors.forename: Jeff D
authors.initials: JD
authors.lastname: Williamson
authors.forename: Susan M
authors.initials: SM
authors.lastname: Resnick
authors.forename: Mark A
authors.initials: MA
authors.lastname: Espeland
mesh_terms: D000368:Aged; D000465:Algorithms; D000544:Alzheimer Disease / Q000000981:diagnostic imaging* / Q000503:physiopathology; D001185:Artificial Intelligence; D005260:Female; D006801:Humans; D016015:Logistic Models; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D059906:Neuroimaging / Q000379:methods; D011859:Radiography; D018570:Risk Assessment